Only severe thrombocytopenia results in bleeding and defective thrombus formation in mice

Risk of arterial thrombosis in patients with primary chronic immune thrombocytopenia: a Danish population-based cohort study

(2012) Mette Nørgaard et al.   BRITISH JOURNAL OF HAEMATOLOGY

Contemporary management of primary immune thrombocytopenia in adults

(2012) S. LAKSHMANAN et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Newly Diagnosed Immune Thrombozytopenia - German Guideline Concerning Initial Diagnosis and Therapy

(2012) W. Eberl et al.   KLINISCHE PADIATRIE

Megakaryocyte-specific RhoA deficiency causes macrothrombocytopenia and defective platelet activation in hemostasis and thrombosis

(2011) I. Pleines et al.   BLOOD

The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia

(2011) C. Neunert et al.   BLOOD

Ischemic Stroke in the Setting of Chronic Immune Thrombocytopenia in an Elderly Patient—A Therapeutic Dilemma

(2011) Anna De La Peña et al.   CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS

Ischaemic stroke: a thrombo-inflammatory disease?

(2011) Bernhard Nieswandt et al.   JOURNAL OF PHYSIOLOGY-LONDON

Genetic and antibody-induced glycoprotein VI deficiency equally protects mice from mechanically and FeCl3-induced thrombosis

(2011) M. BENDER et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Arterial thrombosis—insidious, unpredictable and deadly

(2011) Shaun P Jackson   NATURE MEDICINE

An Overview of the Mechanisms of HIV-Related Thrombocytopenia

(2010) Ana Maria Passos et al.   ACTA HAEMATOLOGICA

Thromboembolic events among adult patients with primary immune thrombocytopenia in the United Kingdom General Practice Research Database

(2010) A. Sarpatwari et al.   HAEMATOLOGICA

Prevalence of thrombocytopenia among patients with chronic hepatitis C: a systematic review

(2010) K. S. Louie et al.   JOURNAL OF VIRAL HEPATITIS

Deficiency of von Willebrand factor protects mice from ischemic stroke

(2009) C. Kleinschnitz et al.   BLOOD

International consensus report on the investigation and management of primary immune thrombocytopenia

(2009) D. Provan et al.   BLOOD

CLEC-2 is an essential platelet-activating receptor in hemostasis and thrombosis

(2009) F. May et al.   BLOOD

Recognition and management of drug-induced cytopenias: the example of idiosyncratic drug-induced thrombocytopenia

(2009) Emmanuel Andres et al.   Expert Opinion On Drug Safety

Drug-induced thrombocytopenia: pathogenesis, evaluation, and management

(2009) J. N. George et al.   Hematology-American Society of Hematology Education Program

Orai1 (CRACM1) is the platelet SOC channel and essential for pathological thrombus formation

(2008) A. Braun et al.   BLOOD

Inflammation induces hemorrhage in thrombocytopenia

(2008) T. Goerge et al.   BLOOD

Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura

(2008) C. E. Neunert et al.   BLOOD

Molecular mechanisms of thrombus formation in ischemic stroke: novel insights and targets for treatment

(2008) G. Stoll et al.   BLOOD

Mutations of the Wiskott–Aldrich Syndrome Protein affect protein expression and dictate the clinical phenotypes

(2008) Hans D. Ochs   IMMUNOLOGIC RESEARCH

Invasive treatment performed for acute myocardial infarction in a patient with immune thrombocytopenic purpura

(2007) Maria Cruz Ferrer Gracia et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY